No Benefit of Rivaroxaban in COVID Outpatients: PREVENT-HD
PREVENT-HD is the largest randomized study to look at anticoagulation in nonhospitalized COVID-19 patients and joins a long list of smaller trials also showing no benefit with this approach.
Source: medscape.com